MedPath

Sublingual Immunotherapy Effect on Allergic Rhinitis

Not Applicable
Recruiting
Conditions
Allergic rhinitis.
Allergic rhinitis due to pollen
Registration Number
IRCT20171105037262N1
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

Having Allergic Rhinitis
Age over 12 years

Exclusion Criteria

Any Respiratory and non-respiratory inflammation such as infection; Recent Massive Surgery;
Severe Pulmonary or Renal Disease; Alcohol Abuse; Sever Addiction; Uncontrolled Diabetes;
Cancer; Autoimmune diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Interleukin 25. Timepoint: First and 24 weeks after intervention. Method of measurement: ELISA.;Interleukin 33. Timepoint: First and 24 weeks after intervention. Method of measurement: ELISA.
Secondary Outcome Measures
NameTimeMethod
Disease severity. Timepoint: At the beginning of the study and 24 weeks after the intervention. Method of measurement: Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath